hcc44 Search Results


94
DSMZ human non small cell lung carcinoma adenocarcinoma cell line hcc 44
Human Non Small Cell Lung Carcinoma Adenocarcinoma Cell Line Hcc 44, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human non small cell lung carcinoma adenocarcinoma cell line hcc 44/product/DSMZ
Average 94 stars, based on 1 article reviews
human non small cell lung carcinoma adenocarcinoma cell line hcc 44 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Broad Institute Inc hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc44, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc44/product/Broad Institute Inc
Average 90 stars, based on 1 article reviews
hcc44 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Creative Bioarray Inc hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc44, supplied by Creative Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc44/product/Creative Bioarray Inc
Average 90 stars, based on 1 article reviews
hcc44 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Taconic Biosciences hcc44 tumor
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc44 Tumor, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc44 tumor/product/Taconic Biosciences
Average 90 stars, based on 1 article reviews
hcc44 tumor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc human luad cell lines hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Human Luad Cell Lines Hcc44, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human luad cell lines hcc44/product/iCell Bioscience Inc
Average 90 stars, based on 1 article reviews
human luad cell lines hcc44 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bristol Myers hcc-44 cell line
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc 44 Cell Line, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc-44 cell line/product/Bristol Myers
Average 90 stars, based on 1 article reviews
hcc-44 cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Bioarray Inc hcc44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc44, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc44/product/Bioarray Inc
Average 90 stars, based on 1 article reviews
hcc44 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CH Instruments hcc-44
(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, <t>HCC44,</t> H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.
Hcc 44, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcc-44/product/CH Instruments
Average 90 stars, based on 1 article reviews
hcc-44 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, HCC44, H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: (A) Percentage growth inhibition (x axis) of KL (red, A549 and H1944 cells), KLP (purple, HCC44, H23, H2122, and H2030 cells), and KP (blue, H2009, H441, and H358 cells) human NSCLC lines treated for 72 hr with 2.5 μM momelotinib or 10 nM trametinib plotted versus degree of baseline IL-6 secretion in conditioned medium (y axis). R2 values and p values for the correlation shown.

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques: Inhibition

(A) IB of the indicated proteins in A549, H1944, HCC44, H2009, H441, and H358 cells treated with or without 500 nM JQ1 for 24 hr. Red cell lines, KL; blue cell lines, KP.

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: (A) IB of the indicated proteins in A549, H1944, HCC44, H2009, H441, and H358 cells treated with or without 500 nM JQ1 for 24 hr. Red cell lines, KL; blue cell lines, KP.

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques:

(A) Crystal violet staining of A549, H1944, HCC44, H23, H2009, H1792, H441, and mouse embryonic fibroblast (MEF) cells In the presence of 2.5 μM MMB and 10 nM Tram each day and/or 500 nM JQ1 every other day (intermittent) for 12 days (See STAR Methods). Red cell lines, KL and KLP; blue cell lines, KP (upper). Quantification of extracted crystal violet in MMB + Tram + JQ1 treated cells was normalized to Tram + JQ1 treated cells (n = 3) (lower).

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: (A) Crystal violet staining of A549, H1944, HCC44, H23, H2009, H1792, H441, and mouse embryonic fibroblast (MEF) cells In the presence of 2.5 μM MMB and 10 nM Tram each day and/or 500 nM JQ1 every other day (intermittent) for 12 days (See STAR Methods). Red cell lines, KL and KLP; blue cell lines, KP (upper). Quantification of extracted crystal violet in MMB + Tram + JQ1 treated cells was normalized to Tram + JQ1 treated cells (n = 3) (lower).

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques: Staining

KEY RESOURCES TABLE

Journal: Cancer cell

Article Title: Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

doi: 10.1016/j.ccell.2018.08.009

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Human: HCC44 , Broad Institute , N/A.

Techniques: Control, Recombinant, Enzyme-linked Immunosorbent Assay, Cell Viability Assay, shRNA, Negative Control, Software, Binding Assay, Expressing